Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Medicaid Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • High Postcancer Medical Bills
  • Federal Workers’ Health Data
  • Cyberattacks on Hospitals
  • ‘Cheap’ Insurance

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Thursday, Jun 16 2016

Full Issue

Personalized Therapies For Diabetics To Be Tested By Boston-Area Collaboration

The Harvard Stem Cell Institute, biotech Semma Therapeutics and two area hospitals are teaming up to create stem cell-based treatments for people with type 1 diabetes. In other diabetes news, a study finds that people with type 2 can have heart health benefits by losing weight, even if they eventually gain it back.

Stat: Stem Cell Factory Opens Door For Trials Of Personalized Diabetes Treatment

In a step that could lead to a new diabetes treatment, several Boston-area hospitals have teamed up with the Harvard Stem Cell Institute and biotech Semma Therapeutics to make personalized cell-based therapies and organize clinical trials. It is one of several initiatives around the country aimed at manufacturing cell-derived treatments, as the hope for such therapies creates a demand for the production of the cells. (Joseph, 6/16)

Reuters: With Diabetes, Losing Weight Lowers Heart Risks, Even If You Regain It

A large weight loss, even if regained, may help overweight people with type 2 diabetes improve their blood sugar control and cholesterol and lower high blood pressure long-term, a new study suggests. Over four years, even those who regained all of a large weight loss had greater improvements in blood sugar than their counterparts who lost no weight or initially lost a smaller amount. (Doyle, 6/15)

And in other public health news —

Reuters: Colon Cancer Screening Saves Lives, Experts Reaffirm

U.S. adults should choose the type of colon cancer screening they feel most comfortable with, the government-backed U.S. Preventive Services Task Force now advises. The updated recommendation, directed at people aged 50 to 75, is a departure from the influential panel's 2008 guidance, which said people in that age group should be screened on a specific time table using one of four tests. (6/15)

The Associated Press: Hints That Antibiotics, C-Sections May Affect Baby Guts

Wednesday's studies closely tracked infants through toddlerhood and concluded that the first two to three years of life are a critical period for budding microbiomes. Still, "what happens when you don't have the right bugs at the right age during that critical period? We don't know the answer," cautioned Dr. Martin Blaser of New York University, who led one of the studies. (Neergard, 6/15)

Fox News: Therapy Helps Girl Diagnosed With Rare Syndrome Overcome Debilitating Pain

Doctors ran a battery of tests and scans but could find nothing physically wrong with her leg. They were baffled as to what was causing such excruciating pain until a physical therapist recommended that Gena take her daughter to Children’s Specialized Hospital in New Brunswick, New Jersey. At the hospital, Dr. Katherine Bentley, the director of the chronic pain program, diagnosed Dinicola with complex regional pain syndrome (CRPS). (Ramsadeen, 6/15)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, April 22
  • Tuesday, April 21
  • Monday, April 20
  • Friday, April 17
  • Thursday, April 16
  • Wednesday, April 15
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF